CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 44 enrolled
Drug / intervention
Liberal transfusion strategy +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02203292
NCT02203292Phase 2Completed

Transfusion Requirements After Head Trauma

University of Sao Paulo·interventional·Posted Jul 29, 2014·Updated Aug 1, 2016

In Brief

A Phase 2 clinical trial evaluating Liberal transfusion strategy and Restrictive transfusion strategy for Traumatic Brain Injury. Completed, enrolled 44 participants across 1 site.

Detailed Summary

TRAHT is a pilot randomized clinical trial designed to evaluate safety and feasibility of two red blood cells transfusion thresholds in moderate or severe traumatic brain injured patients

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBrazil
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 29, 2014
Enrollment StartAug 1, 2014
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.9 years ago

Interventions

Liberal transfusion strategybehavioral

Patients will have red blood cells transfused only if Hb \< 9.0 g/dL

Restrictive transfusion strategybehavioral

Patients will have red blood cells transfused only if Hb \< 7.0 g/dL